CLASS I ONGOING Drug recall · Reported 29 Jan 2025 · FDA Enforcement Report

Fouzee SugarLin Herbal Formula capsules per, Sold recalled

Shoppers- Plaza is recalling Fouzee SugarLin Herbal Formula capsules per, Sold, distributed nationwide in the US. The recall was initiated on 16 Dec 2024 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesBatch # 001, exp. date 09/10/2026
Quantity recalled172 180-count bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0207-2025
FDA event ID
95994
Recalling firm
Shoppers- Plaza, Hawthorne, CA
Classification
Class I
Status
Ongoing
Recall initiated
16 Dec 2024
FDA classified
22 Jan 2025
Reported
29 Jan 2025
Type
Voluntary: Firm initiated
Customers notified by
Press Release
Reason category
Labeling Errors

Timeline

16 Dec 2024Recall initiated by company
22 Jan 2025Classified by FDA+37 days
29 Jan 2025Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Marketed without an Approved NDA/ANDA; FDA laboratory analysis confirmed product tainted with undeclared metformin and glyburide

Product as listed by the FDA

FOUZEE SugarLin HERBAL FORMULA capsules, 180 capsules per bottle, Sold and Distributed by Shoppers-Plaza, Hawthorne, CA 90250. Product of India. UPC 8 26656 69047 7

Where it was distributed

Nationwide via internet sales

Nationwide

Stores named: Online Retailers

Questions about this recall

Is Fouzee SugarLin Herbal Formula capsules per, Sold recalled?

Yes. Shoppers- Plaza recalled Fouzee SugarLin Herbal Formula capsules per, Sold on 16 Dec 2024. The recall is Class I and its status is Ongoing. Recall number D-0207-2025.

Why was it recalled?

Marketed without an Approved NDA/ANDA; FDA laboratory analysis confirmed product tainted with undeclared metformin and glyburide

Which lots are affected?

Batch # 001, exp. date 09/10/2026

Where was it sold?

Nationwide via internet sales

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.